nach oben

Neuropsychology Review

Erschienen in:

01.06.2007 | Original Paper

Meta-Analysis of Neuropsychological Symptoms of Adolescents and Adults with PKU

verfasst von: J. J. Moyle, A. M. Fox, M. Arthur, M. Bynevelt, J. R. Burnett

Erschienen in: Neuropsychology Review | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Phenylketonuria (PKU; OMIM 261600) is an autosomal recessive inborn error of phenylanaline metabolism. PKU is characterized by deficient or defective phenylalanine hydroxylase activity and persistantly increased levels of the essential amino acid phenylalanine in the circulation. The present article examines current understanding of the etiology of PKU, along with a meta-analysis examining neuropsychological and intellectual presentations in continuously treated adolescents and adults. Patients with PKU differed significantly from controls on Full-Scale IQ, processing speed, attention, inhibition, and motor control. Future research utilizing an integrative approach and detailed analysis of specific cognitive domains will assist both the scientist and clinician, and ultimately the patient.

Antshel, K. M., & Waisbren, S. E. (2003). Timing is everything: Executive functions in children exposed to elevated levels of phenylalanine. Neuropsychology, 17, 458–468.PubMedCrossRef

Barkhof, F. (2004). Assessing treatment effects on axonal loss–evidence from MRI monitored clinical trials. Journal of Neurology, 254, 6–12.

Bick, U., Ullrich, K., Stober, U., Moller, H., Schuierer, G., Ludolph, A. C., et al. (1993). White matter abnormalities in patients with treated hyperphenylalaninaemia: Magnetic resonance relaxometry and proton spectroscopy findings. European Journal of Pediatrics, 152, 1012–1020.PubMedCrossRef

Brassington, J. C., & Marsh, N. V. (1998). Neuropsychological aspects of multiple sclerosis. Neuropsychology Review, 8, 43–77.PubMedCrossRef

Bruck, W., Kuhlmann, T., & Stadelmann, C. (2003). Remyelination in multiple sclerosis. Journal of the Neurological Sciences, 206, 181–185.PubMedCrossRef

Brumm, V. L., Azen, C., Moats, R. A., Stern, A. M., Broomand, C., Nelson, M. D., et al. (2004). Neuropsychological outcome of subjects participating in the PKU adult collaborative study: A preliminary review. Journal of Inherited Metabolic Disease, 27, 549– 566.PubMedCrossRef

Brunner, R. L., & Berry, H. K. (1987). Phenylketonuria and sustained attention: The continuous performance test. International Journal of Clinical Neuropsychology, 9, 68–70.

Burgard, P., Rey, F., Rupp, A., Abadie, V., & Rey, J. (1997). Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: Results of a cross-national and cross-sectional study. Pediatric Research, 41, 368–374.PubMedCrossRef

Cerone, R., Schiaffino, M. C., Di Stefano, S., & Veneselli, E. (1999). Phenylketonuria: Diet for life or not? Acta Paediatrica, 88, 664–666.PubMedCrossRef

Chan, R. C., Hoosain, R., Lee, T. M., Fan, Y., & Fong, D. (2003). Are there sub-types of attentional deficits in patients with persisting post-concussive symptoms? A cluster analytical study. Brain Injury, 17, 131–148.PubMedCrossRef

Channon, S., German, E., Cassina, C., & Lee, P. (2004). Executive functioning, memory, and learning in phenylketonuria. Neuropsychology, 18, 613–620.PubMedCrossRef

Channon, S., Mockler, C., & Lee, P. (2005). Executive functioning and speed of processing in phenylketonuria. Neuropsychology, 19, 679–686.PubMedCrossRef

Christ, S. E. (2003). Asbjorn Folling and the discovery of phenylketonuria. Journal of the History of the Neurosciences, 12, 44– 54.PubMedCrossRef

Clarke, J. T., Gates, R. D., Hogan, S. E., Barrett, M., & MacDonald, G. W. (1987). Neuropsychological studies on adolescents with phenylketonuria returned to phenylalanine-restricted diets. American Journal of Mental Retardation, 92, 255–262.PubMed

Cleary, M. A., Walter, J. H., Wraith, J. E., Jenkins, J. P., Alani, S. M., Tyler, K., et al. (1994). Magnetic resonance imaging of the brain in phenylketonuria. Lancet, 344, 87–90.PubMedCrossRef

Coull, J. T. (1998). Neural correlates of attention and arousal: Insights from electrophysiology, functional neuroimaging and psychopharmacology. Progress in Neurobiology, 55, 343–361.PubMedCrossRef

Crinella, F. M., & Yu, J. (2000). Brain mechanisms and intelligence. Psychometric g and executive function. Intelligence, 27, 299–327.CrossRef

De Sonneville, L. M., Boringa, J. B., Reuling, I. E., Lazeron, R. H., Ader, H. J., & Polman, C. H. (2002). Information processing characteristics in subtypes of multiple sclerosis. Neuropsychologia, 40, 1751–1765.PubMedCrossRef

Diamond, A., Prevor, M. B., Callender, G., & Druin, D. P. (1987). Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monographs of the Society for Research in Child Development, 62, 1–205.

Duncan, J. (1986). Disorganisation of behaviour after frontal lobe damage. Cognitive Neuropsychology, 3, 271–290.CrossRef

Duncan, J., Johnson, R., Swales, M., & Freer, C. (1997). Frontal lobe deficits after head injury: Unity and diversity of function. Cognitive Neuropsychology, 14, 713–741.CrossRef

Dyer, C. A. (1999). Pathophysiology of phenylketonuria. Mental Retardation and Developmental Disabilities Research Reviews, 5, 104–112.CrossRef

Dyer, C. A., Kendler, A., Philibotte, T., Gardiner, P., Cruz, J., & Levy, H. L. (1996). Evidence for central nervous system glial cell plasticity in phenylketonuria. Journal of Neuropathology & Experimental Neurology, 55, 795–814.

Feldmann, R., Denecke, J., Grenzebach, M., & Weglage, J. (2005). Frontal lobe-dependent functions in treated phenylketonuria: Blood phenylalanine concentrations and long-term deficits in adolescents and young adults. Journal of Inherited Metabolic Disease, 28, 445–455.PubMedCrossRef

Goldberg, E., & Bougakov, D. (2005). Neuropsychologic assessment of frontal lobe dysfunction. Psychiatric Clinics of North America, 28, 567–580.PubMedCrossRef

Griffiths, P., Paterson, L., & Harvie, A. (1995). Neuropsychological effect of subsequent exposure to phenylalanine in adolescents and young adults with early-treated phenylketonuria. Journal of Intellectual Disability Research, 39, 365–372.PubMedCrossRef

Hedges, L., & Olkin, I. (1985). Statistical Methods for Meta-Analysis. Orlando: Academic Press.

Huijbregts, S., de Sonneville, L., Licht, R., Sergeant, J., & van Spronsen, F. (2002a). Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria. Developmental Neuropsychology, 22, 481–499.PubMedCrossRef

Huijbregts, S. C. J., de Sonneville, L. M., Licht, R., van Spronsen, F. J., & Sergeant, J. A. (2002c). Short-term dietary interventions in children and adolescents with treated phenylketonuria: Effects on neuropsychological outcome of a well-controlled population. Journal of Inherited Metabolic Disease, 25, 419–430.PubMedCrossRef

Huijbregts, S. C., de Sonneville, L. M., Licht, R., van Spronsen, F. J., Verkerk, P. H., & Sergeant, J. A. (2002b). Sustained attention and inhibition of cognitive interference in treated phenylketonuria: Associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia, 40, 7–15.PubMedCrossRef

Huijbregts, S. C. J., De Sonneville, L. M., Van Spronsen, F. J., Berends, I. E., Licht, R., Verkerk, P. H., et al. (2003). Motor function under lower and higher controlled processing demands in early and continuously treated phenylketonuria. Neuropsychology, 17, 369–379.PubMedCrossRef

Huijbregts, S. C. J., de Sonneville, L. M., van Spronsen, F. J., Licht, R., & Sergeant, J. A. (2002). The neuropsychological profile of early and continuously treated phenylketonuria: Orienting, vigilance, and maintenance versus manipulation-functions of working memory. Neuroscience & Biobehavioral Reviews, 26, 697–712.CrossRef

Huttenlocher, P. R. (2000). The neuropathology of phenylketonuria: Human and animal studies. European Journal of Pediatrics, 159, S102–106.PubMedCrossRef

Jervis, G. A. (1953). Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system. Proceedings of the Society for Experimental Biology & Medicine, 82, 514–515.

Jones, L., Cardno, A., Sanders, R., Owen, M., & Williams, J. (2001). Sustained and selective attention as measures of genetic liability to schizophrenia. Schizophrenia Research, 48, 263–272.PubMedCrossRef

Joseph, B., & Dyer, C. A. (2003). Relationship between myelin production and dopamine synthesis in the PKU mouse brain. Journal of Neurochemistry, 86, 615–626.PubMedCrossRef

Knudsen, G. M., Hasselbalch, S., Toft, P. B., Christensen, E., Paulson, O. B., & Lou, H. (1995). Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria. Journal of Inherited Metabolic Disease, 18, 653–664.PubMedCrossRef

Koch, R., Burton, B., Hoganson, G., Peterson, R., Rhead, W., Rouse, B., et al. (2002). Phenylketonuria in adulthood: A collaborative study. Journal of Inherited Metabolic Disease, 25, 333–346.PubMedCrossRef

Kornguth, S., Anderson, M., Markley, J. L., & Shedlovsky, A. (1994). Near-microscopic magnetic resonance imaging of the brains of phenylalanine hydroxylase-deficient mice, normal littermates, and of normal BALB/c mice at 9.4 Tesla. Neuroimage, 1, 220–229.PubMedCrossRef

Krause, W., Halminski, M., McDonald, L., Dembure, P., Salvo, R., Freides, D., et al. (1985). Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man. Journal of Clinical Investigation, 75, 40–48.PubMedCrossRef

Lau, J., Ioannidis, J. P., & Schmid, C. H. (1997). Quantitative synthesis in systematic reviews. Annals of Internal Medicine, 127, 820– 826.PubMed

Leuzzi, V., Bianchi, M. C., Tosetti, M., Carducci, C. L., Carducci, C. A., & Antonozzi, I. (2000). Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria. Journal of Inherited Metabolic Disease, 23, 563–570.PubMedCrossRef

Lou, H. C. (1994). Dopamine precursors and brain function in phenylalanine hydroxylase deficiency. Acta Paediatrica Supplement, 407, 86–88.PubMed

Luciana, M., Hanson, K. L., & Whitley, C. B. (2004). A preliminary report on dopamine system reactivity in PKU: Acute effects of haloperidol on neuropsychological, physiological, and neuroendocrine functions. Psychopharmacology, 175, 18–25.PubMedCrossRef

Luciana, M., Sullivan, J., & Nelson, C. A. (2001). Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria. Child Development, 72, 1637–1652.PubMedCrossRef

MacDonald, A. (2000). Diet and compliance in phenylketonuria. European Journal of Pediatrics, 159, S136–141.PubMedCrossRef

Miller, D. H., Thompson, A. J., & Filippi, M. (2003). Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. Journal of Neurology, 250, 1407–1419.PubMedCrossRef

Miyake, A., Friedman, N. P., Emerson, M. J., Witzki, A. H., & Howerter, A. (2000). The unity and diversity of executive functions and their contributions to complex “frontal lobe” tasks: A latent variable analysis. Cognitive Psychology, 41, 49–100.PubMedCrossRef

Moyle, J., Fox., A., Bynevelt, M., Arthur, M., & Burnett, J. (in press). A neuropsychological profile of off-diet adults with phenylketonuria. Journal of Clinical and Experimental Neuropsychology.

Moyle, J. J., Fox, A. M., Bynevelt, M., Arthur, M., & Burnett, J. R. (2006). Event-related potentials elicited during a visual go-nogo task in adults with phenylketonuria. Clinical Neurophysiology, 117, 2154–2160.PubMedCrossRef

Natale, E., Marzi, C. A., Girelli, M., Pavone, E. F., & Pollman, S. (2006). ERP and fMRI correlates of endogenous and exogenous focusing of visual-spatial attention. European Journal of Neuroscience, 23, 2511–2521.PubMedCrossRef

O’Connor, T. A., & Burns, N. R. (2003). Inspection time and general speed of processing. Personality and Individual Differences, 35, 713–724.CrossRef

Owens, T. (2003). The enigma of multiple sclerosis: Inflammation and neurodegeneration cause heterogeneous dysfunction and damage. Current Opinion in Neurology, 16, 259–265.PubMedCrossRef

Penrose, L. S., & Quastel, J. H. (1937). Metabolic studies in phenylketonuria. The Biochemical Journal, 31, 266–271.PubMed

Pietz, J., Dunckelmann, R., Rupp, A., Rating, D., Meinck, H. M., Schmidt, H., et al. (1998). Neurological outcome in adult patients with early-treated phenylketonuria. European Journal of Pediatrics, 157, 824–830.PubMedCrossRef

Pietz, J., Landwehr, R., Kutscha, A., Schmidt, H., de Sonneville, L., & Trefz, F. K. (1995). Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria. Journal of Pediatrics, 127, 936–943.PubMedCrossRef

Pietz, J., Schmidt, E., Matthis, P., Kobialka, B., et al. (1993). EEGs in phenylketonuria: I. Follow-up to adulthood: II. Short-term diet-related changes in EEGs and cognitive function. Developmental Medicine & Child Neurology, 35, 54–64.CrossRef

Ris, M. D., Williams, S. E., Hunt, M. M., Berry, H. K., & Leslie, N. (1994). Early-treated phenylketonuria: Adult neuropsychologic outcome. Journal of Pediatrics, 124, 388–392.PubMedCrossRef

Ruge, H., & Naumann, E. (2006). Brain-electrical correlates of negative location priming under sustained and tranient attentional context conditions. Journal of Psychophysiology, 20, 160–169.CrossRef

Schmidt, E., Rupp, A., Burgard, P., Pietz, J., et al. (1994). Sustained attention in adult phenylketonuria: The influence of the concurrent phenylalanine-blood-level. Journal of Clinical and Experimental Neuropsychology, 16, 681–688.PubMed

Scriver, C. (2004). Translating knowledge into practice in the “post-genome” era. Acta Paediatrica, 93, 294–300.PubMedCrossRef

Scriver, C. R., & Kaufman, S. (2001). Hyperphenylalaninemia: Phenylalanine Hydroxylase Deficiency. In The Metabolic and Molecular Bases of Inherited Disease (Vol. VIII, pp. 1667–1724).

Sener, R. N. (2003). Diffusion MRI findings in phenylketonuria. European Radiology, 13, L226–229.CrossRef

Somsen, R. J. M., Van Der Molen, M.W., Jennings, J.R., & van Beek, B. (2000). Wisconsin card sorting in adolescents: Analysis of performance, response times and heart rate. Acta Psychologia, 104, 227–257.CrossRef

Stemerdink, N. B. A., Van Der Molen, M. W., Kalverboer, A. F., Van Der Meere, J. J., Huisman, J., de Jong, L. W., et al. (1999). Prefrontal dysfunction in early and continuously treated phenylketonuria. Developmental Neuropsychology, 16, 29–57.CrossRef

Tam, S. Y., Elsworth, J. D., Bradberry, C. W., & Roth, R. H. (1990). Mesocortical dopamine neurons: High basal firing frequency predicts tyrosine dependence of dopamine synthesis. Journal of Neural Transmission - General Section, 81, 97–110.PubMedCrossRef

Thompson, A. J., Tillotson, S., Smith, I., Kendall, B., Moore, S. G., & Brenton, D. P. (1993). Brain MRI changes in phenylketonuria. Associations with dietary status. Brain, 116, 811–821.PubMedCrossRef

Treacy, E. P., Delente, J. J., Elkas, G., Carter, K., Lambert, M., Waters, P. J., et al. (1997). Analysis of phenylalanine hydroxylase genotypes and hyperphenylalaninemia phenotypes using L-[1–13C]phenylalanine oxidation rates in vivo: A pilot study. Pediatric Research, 42, 430–435.PubMedCrossRef

Ullrich, K., Moller, H., Weglage, J., Schuierer, G., Bick, U., Ludolph, A., et al. (1994). White matter abnormalities in phenylketonuria: Results of magnetic resonance measurements. Acta Paediatrica Supplement, 407, 78–82.PubMed

Waisbren, S. E., Brown, M. J., de Sonneville, L. M., & Levy, H. L. (1994). Review of neuropsychological functioning in treated phenylketonuria: An information processing approach. Acta Paediatrica Supplement, 407, 98–103.PubMed

Walter, J., White, F., Hall, S., MacDonald, A., Rylance, G., Boneh, A., et al. (2002). How practical are recommendations for dietary control in phenylketonuria? Lancet, 360, 55–57.PubMedCrossRef

Walter, J. H., White, F., Wraith, J. E., Jenkins, J. P., & Wilson, B. P. (1997). Complete reversal of moderate/severe brain MRI abnormalities in a patient with classical phenylketonuria. Journal of Inherited Metabolic Disease, 20, 367–369.PubMedCrossRef

Wegener, D., Freiwald, W. A., & Kreiter, A. K. (2004). The influence of sustained selective attention on stimulus selectivity in macaque visual area MT. Journal of Neuroscience, 24, 6106–6114.PubMedCrossRef

Weglage, J., Bick, U., Schuierer, G., Pietsch, M., Sprinz, A., Zass, R., et al. (1997a). Progression of cerebral white matter abnormalities in early treated patients with phenylketonuria during adolescence. Neuropediatrics, 28, 239–240.PubMedCrossRef

Weglage, J., Ullrich, K., Pietsch, M., Funders, B., Guttler, F., & Harms, E. (1997b). Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria. Pediatric Research, 42, 378–384.PubMedCrossRef

Weglage, J., Ullrich, K., Pietsch, M., Funders, B., Zass, R., & Koch, H. G. (1996). Untreated non-phenylketonuric-hyperphenyl- alaninaemia: Intellectual and neurological outcome. European Journal of Pediatrics, 155, S26–28.PubMedCrossRef

Weintraub, D., Moberg, P. J., Culbertson, W. C., Duda, J. E., Katz, I. R., & Stern, M. B. (2005). Dimensions of executive function in Parkinson’s disease. Dementia & Geriatric Cognitive Disorders, 20, 140–4.CrossRef

White, D. A., Nortz, M. J., Mandernach, T., Huntington, K., & Steiner, R. D. (2001). Deficits in memory strategy use related to prefrontal dysfunction during early development: Evidence from children with phenylketonuria. Neuropsychology, 15, 221–229.PubMedCrossRef

Titel: Meta-Analysis of Neuropsychological Symptoms of Adolescents and Adults with PKU
verfasst von: J. J. Moyle
A. M. Fox
M. Arthur
M. Bynevelt
J. R. Burnett
Publikationsdatum: 01.06.2007
Verlag: Springer US
Erschienen in: Neuropsychology Review / Ausgabe 2/2007
Print ISSN: 1040-7308
Elektronische ISSN: 1573-6660
DOI: https://doi.org/10.1007/s11065-007-9021-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2007

Functional Magnetic Resonance Imaging in Clinical Practice: Look Before You Leap

A Primer on Functional Magnetic Resonance Imaging

Role of Functional Magnetic Resonance Imaging in Drug Discovery

Clinical Use of Functional Magnetic Resonance Imaging: Reflections on the New CPT Codes

Use of Functional Magnetic Resonance Imaging in the Early Identification of Alzheimer's Disease